<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319201/" ref="ordinalpos=3920&amp;ncbi_uid=4532205&amp;link_uid=PMC3319201" image-link="/pmc/articles/PMC3319201/figure/F3/" class="imagepopup">Figure 3.  From: Consensus Recommendations for Current Treatments and Accelerating Clinical Trials for Patients with Neurofibromatosis Type 2. </a></div><br /><div class="p4l_captionBody">The primary therapeutic targets in the Ras downstream signaling pathway.</div></div>